Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Triple A Study Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · first_quarter · Q1
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Data Broker List Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Triple A Study Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains Issues related to community health centers Issues related to health legal reform
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
VALID Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
VALID Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
U.S. MADE Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
U.S. MADE Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
2021 · fourth_quarter · Q4
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · third_quarter · Q3
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · second_quarter · Q2
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · first_quarter · Q1
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to Peripheral artery disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · fourth_quarter · Q4
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains Issues related to community health centers Issues related to health legal reform
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · third_quarter · Q3
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · second_quarter · Q2
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · first_quarter · Q1
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE